BAC vs V: Which Is the Better Buy?

Side-by-side comparison of Bank of America Corporation and Visa Inc. โ€” fair value, conviction, valuation metrics, and QuantHub research signals. Updated 2026-04-11.
Bank of America Corporation ยท Financial Services
$52.54
+7.3% upside to fair value
Grade B+
VS
Visa Inc. ยท Financial Services
$304.36
+37.7% upside to fair value
High Conviction Grade A-
QuantHub Verdict
V has more upside to fair value (+37.7%). BAC trades at a lower forward P/E (12.1x). These are model outputs โ€” not personalized investment advice. See all research โ†’
Valuation & Fundamentals
Metric BAC V
Current Price $52.54 $304.36
Fair Value Estimate $56.39 $419.00
Upside to Fair Value +7.3% +37.7%
Market Cap $377.1B $586.8B
Forward P/E 12.1x 23.7x
EV / EBITDA 12.8x 22.3x
Price / Sales 2.0x 14.2x
Price / FCF 29.9x 25.6x
Revenue Growth YoY -0.5% +11.3%
Gross Margin 56.1% 81.08%
Operating Margin 19.7% 59.18%
Return on Equity 10.1% 54.22%
Dividend Yield 2.09% 0.83%
FCF Yield 3.35% 3.91%
Analyst Consensus Buy Strong Buy
Investment Thesis
BAC โ€” Bank of America Corporation
Bank of America is a top-two U.S. bank by assets with $3.4 trillion on its balance sheet, generating $30.5 billion in net income in 2025 on the back of 12.5% earnings growth. The bank benefits from scale in consumer deposits, a recovering investment banking franchise, and an expanding digital platform serving 47 million active users. At 12.7x trailing earnings and 1.97x sales, BAC trades at a faiโ€ฆ
V โ€” Visa Inc.
Visa is the world's dominant payment network with $40B in net revenue (FY2025), 50%+ net margins, and a capital-light toll-booth model processing $14.2T in annual payment volume across 257.5B transactions. The business compounds at 10-12% revenue CAGR with operating leverage pushing EPS growth to 12-15% over a cycle, funded by $21.6B in annual free cash flow against only $1.5B in capex. At 28.0x โ€ฆ
Accumulation Zones
Metric BAC V
Zone Low $42.29 $265.00
Zone High $47.93 $300.00
In Buy Zone? No No
โ† BAC Research    V Research โ†’    All Research